Be a PRO & get up to 50% off on select brands. Explore Now
you are here: HomeNewsIndia

Kerala receives 3.5 lakh doses of Covishield

An Indigo regular flight carrying the Covishield vaccine landed at Cochin International Airport at 11.50 AM, a CIAL spokesman said.

May 10, 2021 / 01:18 PM IST
A vial of the Oxford University-AstraZeneca COVID-19 vaccine, which is produced in India and marketed as Covishield (Image: Reuters/Gleb Garanich)

A vial of the Oxford University-AstraZeneca COVID-19 vaccine, which is produced in India and marketed as Covishield (Image: Reuters/Gleb Garanich)

Kerala on Monday received 3.5 lakh doses of Covishield vaccineto combat the COVID-19 pandemic.

An Indigo regular flight carrying the Covishield vaccine landed at Cochin International Airport at 11.50 AM, a CIAL spokesman said.

The state government has placed an order for over one crore doses of vaccine to accelerate the vaccination drive in the state.

Chief Minister Pinarayi Vijayan has said the COVID-19 vaccination drive for those in the age group of 18-45 would be prioritised in Kerala with people having comorbidities given preference.

"It has been informed that the State will get a small portion of doses this month. So, the vaccination drive for those in 18-45 will be prioritised," Vijayan has said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

He has said the state government would initiate steps to ensure the availability of enough vaccines and take the matter up with the Centre.

The Kerala High Court has also sought information from the Centre on the time-frame in which the state government would get its share of vaccines.
PTI
first published: May 10, 2021 01:15 pm

stay updated

Get Daily News on your Browser
Sections
Enjoying Moneycontrol?

How about a quick survey to help us improve our services?

Ok, sure

Maybe next time!